Luis Javier Nannini (Luis J Nannini, L J Nannini)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Venues

The Journal of asthma : official journal of the Association for the Care of Asthma

ERJ open research

American journal of respiratory and critical care medicine

European clinical respiratory journal

Universidad Nacional de Rosario

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidad Nacional de Rosario Jul 27 1994

Argentina

teaching appointment :: Pulmonology; Allergy and Clinical Immunology

Publications

Luis Javier Nannini
Introducing the concept of loss of corticosteroid credit in asthma. The Journal of asthma : official journal of the Association for the Care of Asthma (2024)
Luis Javier Nannini
Introducing the concept of loss of corticosteroid credit in asthma. The Journal of asthma : official journal of the Association for the Care of Asthma (2024)
Luis Javier Nannini, N Brandan, O M Fernández
Bronchodilator Responsiveness Testing with Inhaled Budesonide/Formoterol in Asthma. The Journal of asthma : official journal of the Association for the Care of Asthma (2023)
Luis Javier Nannini
It is time to end our love affair with short-acting β 2 -agonists in asthma? Yes. ERJ open research 9 (1) (2023)
Luis Javier Nannini
It is time to end our love affair with short-acting β 2 -agonists in asthma? Yes. ERJ open research 9 (1) (2023)
Luis Javier Nannini, N S Neumayer, N Brandan, O M Fernández, D M Flores
Asthma-related hospitalizations after implementing SABA-free asthma management with a maintenance and anti-inflammatory reliever regimen. European clinical respiratory journal 9 (1) (2022)
Luis Javier Nannini, Nadia Brandan, Octavio M Fernandez
Achieving zero asthma-related hospitalisations in the world´s first SABA-free Asthma Center in Argentina. The Journal of asthma : official journal of the Association for the Care of Asthma (2022)
Luis Javier Nannini, S Luhning, R A Rojas, J M Antunez, J L Miguel Reyes, C Cano Salas, Raphael Stelmach
Position statement: asthma in Latin America. IS short-acting beta-2 agonist helping or compromising asthma management? The Journal of asthma : official journal of the Association for the Care of Asthma 58 (8) (2020)
Luis Javier Nannini
Short-Acting β2-Agonist Use Could Be a Confounding Factor for Interpreting Increased IL-6. American journal of respiratory and critical care medicine 202 (9) (2020)
Luis Javier Nannini
Is It Time to Leave Behind the Concept of Asthma Control and Severity Steps? The Journal of asthma : official journal of the Association for the Care of Asthma 58 (3) (2019)

Luis Javier Nannini.css-eqlu8i{font-size:small;padding-left:4px;} (Luis J Nannini, L J Nannini)

Publication Activity (10 Years)

Top Topics

Top Venues

Luis Javier Nannini (Luis J Nannini, L J Nannini)